Clinical trials recruiting for Malignant Pleural Effusions (Mpe)

Phase breakdown

Drugs and treatments being studied

Self-screener

Recruiting trials

• ARMSTRONG - Air entRainMent vS sTandard tReatment in nOn-expandable luNG
  NCT06959719 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Ex Vivo Drug Response Profiling and Outcome Prediction in Lung Adenocarcinoma
  NCT07636252 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• First-in-Human Expanded Cohort Study of Intrapleural Administration of TolueneSulfonamide in Patients With Malignant Pleural Effusion
  NCT07332858 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

Related conditions

Trials recruiting for Malignant Pleural Effusions (Mpe) often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Malignant Pleural Effusions (Mpe) trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.